New study to check hepatitis a protection in liver patients

NCT ID NCT07433881

First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This study looks at how many adults with cirrhosis have natural protection against hepatitis A and how well a single dose of the vaccine works for those who are not immune. Researchers will test blood samples from 360 participants in India. The goal is to provide better guidance for vaccination policies in people with chronic liver disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Liver and Biliary Sciences

    New Delhi, National Capital Territory of Delhi, 110070, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.